OTLK
Outlook Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.47
+1.93%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 0.80x
- P/S forward
- 2.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -10.98x
- Price / sales
- -98.14x
- Price / cash flow
- -2.00x
Enterprise value
- Enterprise value
- $121.3M
- EV / sales
- -104.32x
- EV / EBITDA
- -1.95x
- EV / EBIT
- -2.18x
- Market cap
- $114.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026